Ankylosing Spondylitis Trial, Recruiting (NCT06988813)

Ankylosing Spondylitis Trial, Recruiting NCT06988813 Sponsor: Nanfang Hospital, Southern Medical University Condition: Ankylosing Spondylitis

Printed from Voxsanity (voxsanity.com.au) — NCT06988813 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ankylosing Spondylitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You received care at Nanfang Hospital, Southern Medical University, at some point between 2010 and 2030.
You are willing to take part and have signed a consent form (for the ongoing part of the study), or you visited the hospital between April 2010 and April 2024 and are not expected to return (for the historical records part of the study).
You are between 10 and 59 years old.
You have been formally diagnosed with a condition called spondyloarthritis, confirmed using one of two internationally recognised sets of diagnostic guidelines from 2009 or 2011 (confirm with trial site if unsure which applies to you).

Who may not be able to join:

You are currently pregnant, trying to become pregnant, or breastfeeding.
You have moderate to severe heart failure (classified as Class 3 or 4 by your doctor).
You have an active stomach ulcer or are currently experiencing gastrointestinal bleeding.
The research team feels, for any reason, that joining this study would not be appropriate for you.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0086-20-18665000156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06988813

Sponsor: Nanfang Hospital, Southern Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Ankylosing Spondylitis

Trial contact: 0086-20-18665000156

More information: https://clinicaltrials.gov/study/NCT06988813

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You received care at Nanfang Hospital, Southern Medical University, at some point between 2010 and 2030.
You are willing to take part and have signed a consent form (for the ongoing part of the study), or you visited the hospital between April 2010 and April 2024 and are not expected to return (for the historical records part of the study).
You are between 10 and 59 years old.
You have been formally diagnosed with a condition called spondyloarthritis, confirmed using one of two internationally recognised sets of diagnostic guidelines from 2009 or 2011 (confirm with trial site if unsure which applies to you).

Who may not be able to join:

You are currently pregnant, trying to become pregnant, or breastfeeding.
You have moderate to severe heart failure (classified as Class 3 or 4 by your doctor).
You have an active stomach ulcer or are currently experiencing gastrointestinal bleeding.
The research team feels, for any reason, that joining this study would not be appropriate for you.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nanfang Hospital, Southern Medical University

Registry

ClinicalTrials.gov

Start date

17 May 2025

Est. completion

30 April 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

SpA dateset

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov